Source: Pharmabiz

Diagnomics: Diagnomics introduces ACMG 59 report for personalized genetic testing

Diagnomics, a leading genetic testing company, has developed a new ACMG 59 report that is available to healthcare providers and their patients to complement Diagnomics' portfolio of Personalized Genomics.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Min Seob Lee's photo - Co-Founder & CEO of Diagnomics

Co-Founder & CEO

Min Seob Lee

CEO Approval Rating

90/100